Category: Hong Kong Corporate News

Hong Kong Corporate News

Sunshine Oilsands Forms Joint Venture in China for Geothermal and Energy-Saving Projects

Minichart

May 10, 2026

Sunshine Oilsands Ltd. Announces Formation of Joint Venture ...

Continue Reading 0

Hong Kong Corporate News

MicroPort CardioFlow Medtech Receives CE Approval for ENO Series Pacemakers and Complete LBBAP Therapy Solution 1

Minichart

May 10, 2026

MicroPort CardioFlow Medtech Corporation: CE Approval of ENO...

Continue Reading 0

Hong Kong Corporate News

Shun Ho Property Announces HK$48 Million Off-Market Share Buy-Back and Special Dividend for Magnificent Hotel Shareholders

Minichart

May 10, 2026

Magnificent Hotel, Shun Ho Property, and Shun Ho Holdings Jo...

Continue Reading 0

Hong Kong Corporate News

Shanghai Conant Optical Announces Cancellation of Repurchased H Shares Under 2026 Repurchase Plan

Minichart

May 10, 2026

Shanghai Conant Optical Announces Cancellation of Repurchase...

Continue Reading 0

Hong Kong Corporate News

FEG Holdings Rights Issue 2026: Terms, Procedures, and Key Dates for Shareholders

Minichart

May 10, 2026

FEG Holdings Corporation Limited Rights Issue: Detailed Inve...

Continue Reading 0

Hong Kong Corporate News

FEG Holdings Corporation Limited Proposed Rights Issue 2026: Details, Timetable, Subscription Price, Compensatory Arrangements, and Use of Proceeds

Minichart

May 10, 2026

FEG Holdings Corporation Limited Announces Major Rights Issu...

Continue Reading 0

Hong Kong Corporate News

Beijing Capital International Airport Approved to Issue Medium-Term Notes and Short-Term Debentures in 2026 1

Minichart

May 10, 2026

Beijing Capital International Airport Company Limited: Appro...

Continue Reading 0

Hong Kong Corporate News

Geely Automobile Issues RMB2 Billion Medium-Term Notes Due 2028 for Working Capital in China

Minichart

May 10, 2026

Geely Automobile Holdings Limited Issues RMB2 Billion Medium...

Continue Reading 0

Hong Kong Corporate News

Shanghai Henlius Biotech Receives FDA Approval for Phase 1 Clinical Trial of HLX05-N Cetuximab Biosimilar for Metastatic Colorectal Cancer

Minichart

May 10, 2026

Shanghai Henlius Biotech - FDA Approval of HLX05-N Phase 1 I...

Continue Reading 0

Hong Kong Corporate News

European Commission Approves Two New Indications for Serplulimab (HETRONIFLY) by Shanghai Henlius Biotech

Minichart

May 10, 2026

Henlius Biotech: EC Approves Two New Indications for Serplul...

Continue Reading 0